Insider Transactions in Q1 2025 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2025
|
Timothy A Springer Director |
BUY
Open market or private purchase
|
Direct |
4,022
+0.05%
|
$72,396
$18.0 P/Share
|
|
Jan 13
2025
|
Timothy A Springer Director |
BUY
Open market or private purchase
|
Direct |
16,945
+0.1%
|
$288,065
$17.32 P/Share
|
|
Jan 10
2025
|
Christopher M Jewell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+12.59%
|
$27,000
$3.23 P/Share
|
|
Jan 06
2025
|
Blaine Davis Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,028
-4.08%
|
$64,448
$16.83 P/Share
|
|
Jan 06
2025
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
8,708
-4.09%
|
$139,328
$16.83 P/Share
|
|
Jan 06
2025
|
Emily English Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
906
-2.2%
|
$14,496
$16.83 P/Share
|
|
Jan 06
2025
|
Christopher M Jewell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,286
-2.35%
|
$20,576
$16.83 P/Share
|
|
Jan 06
2025
|
Milos Miljkovic Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
948
-2.61%
|
$15,168
$16.83 P/Share
|
|
Jan 06
2025
|
Metin Kurtoglu Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,458
-3.8%
|
$39,328
$16.83 P/Share
|
|
Jan 03
2025
|
Blaine Davis Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,961
-3.85%
|
$63,376
$16.72 P/Share
|
|
Jan 03
2025
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
8,563
-3.87%
|
$137,008
$16.72 P/Share
|
|
Jan 03
2025
|
Emily English Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
891
-2.12%
|
$14,256
$16.72 P/Share
|
|
Jan 03
2025
|
Christopher M Jewell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,264
-2.26%
|
$20,224
$16.72 P/Share
|
|
Jan 03
2025
|
Milos Miljkovic Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
932
-2.5%
|
$14,912
$16.72 P/Share
|
|
Jan 03
2025
|
Metin Kurtoglu Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,417
-3.6%
|
$38,672
$16.72 P/Share
|
|
Jan 02
2025
|
Patrick J Zenner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+20.04%
|
-
|
|
Jan 02
2025
|
Blaine Davis Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+17.63%
|
-
|
|
Jan 02
2025
|
Emily English Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,100
+27.7%
|
-
|
|
Jan 02
2025
|
Christopher M Jewell Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,100
+22.32%
|
-
|
|
Jan 02
2025
|
Carsten Brunn President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,500
+20.62%
|
-
|
|
Jan 02
2025
|
Kemal Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+23.35%
|
-
|
|
Jan 02
2025
|
Timothy A Springer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+0.03%
|
-
|
|
Jan 02
2025
|
Timothy C Barabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+9.64%
|
-
|
|
Jan 02
2025
|
Murat Kalayoglu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+0.51%
|
-
|
|
Jan 02
2025
|
Milos Miljkovic Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+33.76%
|
-
|
|
Jan 02
2025
|
Nishan M De Silva Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+22.88%
|
-
|
|
Jan 02
2025
|
Carrie Smith Cox Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+14.26%
|
-
|
|
Jan 02
2025
|
Michael Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+3.42%
|
-
|
|
Jan 02
2025
|
Metin Kurtoglu Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,100
+19.34%
|
-
|